A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO

PHASE2RecruitingINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

September 12, 2025

Primary Completion Date

June 30, 2028

Study Completion Date

June 30, 2028

Conditions
Neovascular Age-Related Macular Degeneration (NVAMD)Branch Retinal Vein Occlusion (BRVO)
Interventions
DRUG

EYE103

EYE103 is a humanized antibody formulated for intravitreal administration

DRUG

Aflibercept 2.0 mg

Aflibercept 2.0 mg is a commercially available anti-VEGF treatment formulated for intravitreal administration for use in patients with Neovascular Age-Related Macular Degeneration (NVAMD). Aflibercept 2.0 mg is only administered to 2 cohorts of Incomplete Responders (IR) with NVAMD in combination with Low Dose or High Dose EYE103.

Trial Locations (47)

21740

RECRUITING

Hagerstown, Maryland, Hagerstown

RECRUITING

Hagerstown, MD, Hagerstown

27511

RECRUITING

Cary, North Carolina, Cary

27587

RECRUITING

Wake Forest, NC, Wake Forest

RECRUITING

Wake Forest, North Carolina, Wake Forest

28803

RECRUITING

Asheville, North Carolina, Asheville

29169

RECRUITING

West Columbia, SC, West Columbia

RECRUITING

West Columbia, South Carolina, West Columbia

33308

RECRUITING

Fort Lauderdale, Florida, Fort Lauderdale

RECRUITING

Fort Lauderdale, FL, Fort Lauderdale

37203

RECRUITING

Nashville, Tennessee, Nashville

RECRUITING

Nashville, TN, Nashville

37922

RECRUITING

Knoxville, Tennessee, Knoxville

38138

RECRUITING

Germantown, Tennessee, Germantown

39110

RECRUITING

Madison, Mississippi, Madison

RECRUITING

Madison, MS, Madison

60439

RECRUITING

Lemont, Illinois, Lemont

RECRUITING

Lemont, IL, Lemont

75075

RECRUITING

Plano, Texas, Plano

75231

RECRUITING

Dallas, Texas, Dallas

RECRUITING

Dallas, TX, Dallas

76028

RECRUITING

Burleson, Texas, Burleson

76087

RECRUITING

Willow Park, Texas, Willow Park

77384

NOT_YET_RECRUITING

The Woodlands, Texas, The Woodlands

RECRUITING

The Woodlands, TX, The Woodlands

77401

RECRUITING

Bellaire, Texas, Bellaire

RECRUITING

Bellaire, TX, Bellaire

78240

RECRUITING

San Antonio, Texas, San Antonio

RECRUITING

San Antonio, TX, San Antonio

78666

RECRUITING

San Marcos, Texas, San Marcos

78681

RECRUITING

Round Rock, TX, Round Rock

78705

RECRUITING

Austin, Texas, Austin

RECRUITING

Austin, TX, Austin

78781

RECRUITING

Round Rock, Texas, Round Rock

79606

RECRUITING

Abilene, Texas, Abilene

85255

RECRUITING

Scottsdale, Arizona, Scottsdale

RECRUITING

Scottsdale, AZ, Scottsdale

91204

RECRUITING

Glendale, California, Glendale

RECRUITING

Glendale, CA, Glendale

92705

RECRUITING

Santa Ana, California, Santa Ana

94040

RECRUITING

Mountain View, California, Mountain View

95356

RECRUITING

Modesto, California, Modesto

95825

RECRUITING

Sacramento, CA, Sacramento

RECRUITING

Sactamento, California, Sacramento

95841

RECRUITING

Sacramento, California, Sacramento

07003

RECRUITING

Bloomfield, New Jersey, Bloomfield

RECRUITING

Bloomfield, NJ, Bloomfield

Sponsors

Lead Sponsor

All Listed Sponsors
lead

EyeBiotech Ltd.

INDUSTRY

NCT07205887 - A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO | Biotech Hunter | Biotech Hunter